Back
Phathom Pharmaceuticals Stock Price Chart
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
PHAT
Phathom Pharmaceuticals
Last Price:
$4.89
Seasonality Move:
17.73%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.81 | Sell |
| 20-day SMA: | 5.59 | Sell |
| 50-day SMA: | 5.8 | Sell |
| 200-day SMA: | 10.83 | Sell |
| 8-day EMA: | 5.53 | Sell |
| 20-day EMA: | 5.69 | Sell |
| 50-day EMA: | 6.18 | Sell |
| 200-day EMA: | 9.16 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | -36886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.9 - 6.32) | Sell |
| Bollinger Bands (100): | (4.95 - 9.73) | Sell |
Phathom Pharmaceuticals Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.88 while PHAT 8-day simple moving average is 5.81, which is a Sell signal.
-
The stock price of PHAT is 4.88 while Phathom Pharmaceuticals 20-day SMA is 5.59, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 5.80 while PHAT share price is 4.88, making it a Sell technically.
-
PHAT stock price is 4.88 and Phathom Pharmaceuticals 200-day simple moving average is 10.83, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
11
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $4.88. The Score for PHAT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
339.8M
Price in USD:
4.88
Share Volume:
799.2K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
4.07
Sell
11
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 4.88 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.88 while PHAT 8-day exponential moving average is 5.53, which is a Sell signal.
-
The stock price of PHAT is 4.88 while Phathom Pharmaceuticals 20-day EMA is 5.69, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 6.18 while PHAT share price is 4.88, making it a Sell technically.
-
PHAT stock price is 4.88 and Phathom Pharmaceuticals 200-day simple moving average is 9.16, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.22 per share, an increase this year of $0.78 per share, and an increase next year of $2.19 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 40.78, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (4.9 - 6.32), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (4.95 - 9.73), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.